Cellares to downsize following Bristol Myers Squibb decision to end partnership

Tuesday, August 25, 2026alundin@endeavorb2b.com (Andy Lundin)View original

The loss is forcing the automated cell therapy manufacturer to resize, despite doubling the number of customers in 2026.

Read the full article on the original site.